A new study has highlighted important evidence supporting the use of medical cannabis in the treatment of cancer. Studies show that therapy cannabis can not only reduce symptoms, but can also compete with the disease.
Recently published Frontiers In oncology, the study’s role tries to establish a scientific consent Canbis In cancer care.
Ryan Castle, the research director of the entire Health Oncology Institute and lead author of the study, said that the purpose of this analysis was to collect a huge array of study and address the ongoing debate by collecting a one.
“Our goal was to determine scientific consent on the subject of medical cannabis, an area that dominated a war between a long-cherished studies,” Castle said that as said that it was said. The Guardian.
Research, which was funded by Cancer Playbook, is based on a review of more than 10,000 studies related to the entire House Oncology Institute to collect and analyze the patient-reported data, more than 10,000 studies related to medical cannabis and cancer. This giant pool of research allegedly crosses the scale of any previous study in the region.
Despite the boundaries imposed by the restricted legal status of cannabis, the researchers used a comprehensive spectrum of observation and laboratory-based studies. These include animal testing and cell research that discover the effects of cannabis on the development of tumors.
Castle’s team tried to include several of these studies to ensure comprehensive reviews.
Castle said, “Whether or not to go beyond prejudice or not-it was necessary to use a fundamentally inclusive functioning on a large scale based on mathematical arguments.”
The analysis showed a clear pattern. This identified the study with positive, neutral and negative ideas on the effects of cannabis on the symptoms of cancer, such as hunger loss, inflammation and even tumor cell death process, known as apoptosis.
The conclusions were striking, especially about the ability to address symptoms such as a nausea and loss of appetite. The most notable discovery of the study was the capacity of canbis to directly target cancer cells, with evidence that it can prevent their spread and promote cell death.
Although the ability of the cannabis has been fulfilled with some doubt as a treatment for cancer, due to concerns on the link of the use disorders of the substance, both support and criticism have been received.
Oncologist Donald AbramsEmeritus, a professor at the University of California, San Francisco, questioned the validity of these conclusions.
Abrams, who have a widespread experience for treating cancer patients in San Francisco, noted the therapeutic value of cannabis in managing cancer symptoms, including pain, nausea and anxiety. But he expressed doubts about the ability of cannabis to cure cancer, saying, “If Canbis fixes cancer, I could not appreciate it,” he told the Guardian
Castle, however, is optimistic, encourages patient consequences as a reasons for reasons for cannabis cancer’s ability to fight cancer.
He hopes that this meta-analisis will motivate the US drug enforcement administration (DEA) to reconsider the federal classification of cannabis, lifting the current research restrictions.
